Metacrine, Inc.
3985 Sorrento Valley Blvd., Suite C
San Diego, CA 92121
(858) 369-7800
October 13, 2021
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Dillon Hagius
Re: | Metacrine, Inc. | |
Registration Statement on Form S-3 | ||
File No. 333-260023 |
Acceleration Request | ||||
Requested Date: | Friday, October 15, 2021 | |||
Requested Time: | 4:00 p.m. Eastern Time |
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Metacrine, Inc. hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective at 4:00 p.m. Eastern Time on Friday, October 15, 2021, or as soon thereafter as is practicable.
If you have any questions regarding this request, please contact Karen Deschaine of Cooley LLP at (858) 550-6088 or Carlos Ramirez of Cooley LLP at (858) 550-6157.
Sincerely, | ||
METACRINE, INC. | ||
By: | /s/ Trisha Millican | |
Trisha Millican | ||
Chief Financial Officer |